Utilizing an integrated approach that incorporates a strong background in clinical research, clinical experience and public health training, Dr. Schroy’s research activities focus primarily on the development, implementation and evaluation of model programs for community-based colorectal cancer control. Current ongoing studies include: (1) exploring the role of shared decision-making as a strategy for increasing patient participation in colorectal cancer screening; (2) developing a risk assessment tool for predicting the presence of advanced neoplasia at screening colonoscopy; (3) evaluating the feasibility and validity of novel colorectal cancer screening strategies such as stool-based DNA testing and virtual colonoscopy; and (4) implementation of quality measures related to colorectal cancer screening.
- Thomas Jefferson University, MD
- Boston University School of Public Health, MPH
- Haverford College, BS
- Published on 7/1/2017
DeGroff A, Schroy PC, Morrissey KG, Slotman B, Rohan EA, Bethel J, Murillo J, Ren W, Niwa S, Leadbetter S, Joseph D. Patient Navigation for Colonoscopy Completion: Results of an RCT. Am J Prev Med. 2017 Sep; 53(3):363-372. PMID: 28676254.
- Published on 6/23/2017
Kluge MA, Williams JL, Wu CK, Jacobson BC, Schroy PC, Lieberman DA, Calderwood AH. Inadequate Boston Bowel Preparation Scale scores predict the risk of missed neoplasia on the next colonoscopy. Gastrointest Endosc. 2018 Mar; 87(3):744-751. PMID: 28648575.
- Published on 5/1/2017
Le ST, Lash BR, Schroy PC, Calderwood AH. Physician Perceptions of Surveillance Follow-up Colonoscopy in Older Adults. J Am Board Fam Med. 2017 May-Jun; 30(3):371-373. PMID: 28484069.
- Published on 2/22/2017
Seibert RG, Hanchate AD, Berz JP, Schroy PC. National Disparities in Colorectal Cancer Screening Among Obese Adults. Am J Prev Med. 2017 Aug; 53(2):e41-e49. PMID: 28236517.
- Published on 10/31/2016
Rohan EA, Slotman B, DeGroff A, Morrissey KG, Murillo J, Schroy P. Refining the Patient Navigation Role in a Colorectal Cancer Screening Program: Results From an Intervention Study. J Natl Compr Canc Netw. 2016 Nov; 14(11):1371-1378. PMID: 27799508.
- Published on 6/3/2016
Lowery JT, Ahnen DJ, Schroy PC, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review. Cancer. 2016 Sep 01; 122(17):2633-45. PMID: 27258162.
- Published on 6/3/2016
Ahnen DJ, Schroy PC, Weber TK. Regarding "Colorectal Cancer Screening Quality Measures: Beyond Colonoscopy". Clin Gastroenterol Hepatol. 2016 11; 14(11):1668-1669. PMID: 27266981.
- Published on 1/19/2016
Schroy PC, Duhovic E, Chen CA, Heeren TC, Lopez W, Apodaca DL, Wong JB. Risk Stratification and Shared Decision Making for Colorectal Cancer Screening: A Randomized Controlled Trial. Med Decis Making. 2016 May; 36(4):526-35. PMID: 26785715.
- Published on 1/1/2016
Calderwood AH, Schroy PC, Kluge MA, Cabral HJ, Burgess JF. Predictors of Adherence to Post-Polypectomy Surveillance Colonoscopy. J Health Care Poor Underserved. 2016; 27(1):261-279. PMID: 27763469.
- Published on 12/18/2015
Berger BM, Schroy PC, Dinh TA. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness. Clin Colorectal Cancer. 2016 Sep; 15(3):e65-74. PMID: 26792032.
View 167 more publications: View full profile at BUMC